Schedule 13G ownership disclosure

Eton Pharmaceuticals Inc

Security class unavailable · CUSIP: 29772L108

Event date: 2024-12-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,397,669
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-24-000751
Form type
SC 13G
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
Dec 09, 2024
Reporting period
Dec 02, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub